Redistribution of sphingosine 1-phosphate by sphingosine kinase 2 contributes to lymphopenia

Journal of Immunology

Volumn 184, Issue 8, 2010, Pages 4133-4142

  Sensken, Sven Christian ^a   Bode, Constantin ^a   Nagarajan, Manju ^a   Peest, Ulrike ^a   Pabst, Oliver ^a   Gräler, Markus H ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYPYRIDOXINE; LYASE; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE KINASE 2; DRUG DERIVATIVE; LYSOPHOSPHOLIPID; PHOSPHOTRANSFERASE; SPHINGOSINE; SPHINGOSINE 1-PHOSPHATE; SPHINGOSINE KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CONTROLLED STUDY; ENDOTHELIUM CELL; ERYTHROCYTE TRANSFUSION; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; LYMPHOCYTOPENIA; LYMPHOID TISSUE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SPLEEN CELL; WILD TYPE; ANIMAL; B LYMPHOCYTE; BAGG ALBINO MOUSE; BLOOD; C57BL MOUSE; CATALYSIS; COCULTURE; ENZYMOLOGY; GENETICS; IMMUNOLOGY; METABOLISM; MOUSE MUTANT; PATHOLOGY; PHOSPHORYLATION; PHYSIOLOGY; PROTEIN TRANSPORT; T LYMPHOCYTE SUBPOPULATION; VASCULAR ENDOTHELIUM;

ANIMALS; B-LYMPHOCYTE SUBSETS; CATALYSIS; CELLS, CULTURED; COCULTURE TECHNIQUES; ENDOTHELIUM, VASCULAR; HUMANS; LYMPHOID TISSUE; LYMPHOPENIA; LYSOPHOSPHOLIPIDS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; PHOSPHORYLATION; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); PROTEIN TRANSPORT; SPHINGOSINE; T-LYMPHOCYTE SUBSETS;

EID: 77952755702     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0903358     Document Type: Article

References (35)

1. Rosen, H., and E. J. Goetzl. 2005. Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network. Nat. Rev. Immunol. 5: 560-570.
2. Schwab, S. R., and J. G. Cyster. 2007. Finding a way out: lymphocyte egress from lymphoid organs. Nat. Immunol. 8: 1295-1301.
3. Matloubian, M., C. G. Lo, G. Cinamon, M. J. Lesneski, Y. Xu, V. Brinkmann, M. L. Allende, R. L. Proia, and J. G. Cyster. 2004. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature 427: 355-360. (Pubitemid 38133663)
4. Pappu, R., S. R. Schwab, I. Cornelissen, J. P. Pereira, J. B. Regard, Y. Xu, E. Camerer, Y. W. Zheng, Y. Huang, J. G. Cyster, and S. R. Coughlin. 2007. Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-1-phosphate. Science 316: 295-298.
5. Gräler, M. H., and E. J. Goetzl. 2004. The immunosuppressant FTY720 downregulates sphingosine 1-phosphate G-protein-coupled receptors. FASEB J. 18: 551-553.
6. Mandala, S., R. Hajdu, J. Bergstrom, E. Quackenbush, J. Xie, J. Milligan, R. Thornton, G. J. Shei, D. Card, C. Keohane, et al. 2002. Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists. Science 296: 346-349.
7. Wei, S. H., H. Rosen, M. P. Matheu, M. G. Sanna, S. K. Wang, E. Jo, C. H. Wong, I. Parker, and M. D. Cahalan. 2005. Sphingosine 1-phosphate type 1 receptor agonism inhibits transendothelial migration of medullary T cells to lymphatic sinuses. Nat. Immunol. 6: 1228-1235.
8. Schwab, S. R., J. P. Pereira, M. Matloubian, Y. Xu, Y. Huang, and J. G. Cyster. 2005. Lymphocyte sequestration through S1P lyase inhibition and disruption of S1P gradients. Science 309: 1735-1739.
9. Goetzl, E. J., and S. An. 1998. Diversity of cellular receptors and functions for the lysophospholipid growth factors lysophosphatidic acid and sphingosine 1-phosphate. FASEB J. 12: 1589-1598.
10. Paugh, S. W., S. G. Payne, S. E. Barbour, S. Milstien, and S. Spiegel. 2003. The immunosuppressant FTY720 is phosphorylated by sphingosine kinase type 2. FEBS Lett. 554: 189-193. (Pubitemid 37324838)
11. Shida, D., K. Takabe, D. Kapitonov, S. Milstien, and S. Spiegel. 2008. Targeting SphK1 as a new strategy against cancer. Curr. Drug Targets 9: 662-673.
12. Zemann, B., B. Kinzel, M. Müller, R. Reuschel, D. Mechtcheriakova, N. Urtz, F. Bornancin, T. Baumruker, and A. Billich. 2006. Sphingosine kinase type 2 is essential for lymphopenia induced by the immunomodulatory drug FTY720. Blood 107: 1454-1458. (Pubitemid 43242381)
13. Kharel, Y., S. Lee, A. H. Snyder, S. L. Sheasley-O'neill, M. A. Morris, Y. Setiady, R. Zhu, M. A. Zigler, T. L. Burcin, K. Ley, et al. 2005. Sphingosine kinase 2 is required for modulation of lymphocyte traffic by FTY720. J. Biol. Chem. 280: 36865-36872.
14. Yoshimoto, T., M. Furuhata, S. Kamiya, M. Hisada, H. Miyaji, Y. Magami, K. Yamamoto, H. Fujiwara, and J. Mizuguchi. 2003. Positive modulation of IL-12 signaling by sphingosine kinase 2 associating with the IL-12 receptor β 1 cytoplasmic region. J. Immunol. 171: 1352-1359. (Pubitemid 36900067)
15. Samy, E. T., C. A. Meyer, P. Caplazi, C. L. Langrish, J. M. Lora, H. Bluethmann, and S. L. Peng. 2007. Cutting edge: modulation of intestinal autoimmunity and IL-2 signaling by sphingosine kinase 2 independent of sphingosine 1-phosphate. J. Immunol. 179: 5644-5648.
16. Allende, M. L., T. Sasaki, H. Kawai, A. Olivera, Y. Mi, G. van Echten-Deckert, R. Hajdu, M. Rosenbach, C. A. Keohane, S. Mandala, et al. 2004. Mice deficient in sphingosine kinase 1 are rendered lymphopenic by FTY720. J. Biol. Chem. 279: 52487-52492.
17. Mizugishi, K., T. Yamashita, A. Olivera, G. F. Miller, S. Spiegel, and R. L. Proia. 2005. Essential role for sphingosine kinases in neural and vascular development. Mol. Cell. Biol. 25: 11113-11121.
18. Pham, T. H., P. Baluk, Y. Xu, I. Grigorova, A. J. Bankovich, R. Pappu, S. R. Coughlin, D. M. McDonald, S. R. Schwab, and J. G. Cyster. 2010. Lymphatic endothelial cell sphingosine kinase activity is required for lymphocyte egress and lymphatic patterning. J. Exp. Med. 207: 17-27, S1-S4 .
19. Venkataraman, K., Y. M. Lee, J. Michaud, S. Thangada, Y. Ai, H. L. Bonkovsky, N. S. Parikh, C. Habrukowich, and T. Hla. 2008. Vascular endothelium as a contributor of plasma sphingosine 1-phosphate. Circ. Res. 102: 669-676.
20. Camerer, E., J. B. Regard, I. Cornelissen, Y. Srinivasan, D. N. Duong, D. Palmer, T. H. Pham, J. S. Wong, R. Pappu, and S. R. Coughlin. 2009. Sphingosine-1-phosphate in the plasma compartment regulates basal and inflammation-induced vascular leak in mice. J. Clin. Invest. 119: 1871-1879.
21. Vogel, P., M. S. Donoviel, R. Read, G. M. Hansen, J. Hazlewood, S. J. Anderson, W. Sun, J. Swaffield, and T. Oravecz. 2009. Incomplete inhibition of sphingosine 1-phosphate lyase modulates immune system function yet prevents early lethality and non-lymphoid lesions. PLoS One 4: e4112.
22. Weber, C., A. Krueger, A. Münk, C. Bode, P. P. Van Veldhoven, and M. H. Gräler. 2009. Discontinued postnatal thymocyte development in sphingosine 1-phosphate-lyase-deficient mice. J. Immunol. 183: 4292-4301.
23. Peest, U., S. C. Sensken, P. Andréani, P. Hänel, P. P. Van Veldhoven, and M. H. Gräler. 2008. S1P-lyase independent clearance of extracellular sphingosine 1-phosphate after dephosphorylation and cellular uptake. J. Cell. Biochem. 104: 756-772.
24. Andréani, P., and M. H. Gräler. 2006. Comparative quantification of sphingolipids and analogs in biological samples by high-performance liquid chromatography after chloroform extraction. Anal. Biochem. 358: 239-246.
25. Sensken, S. C., C. Bode, and M. H. Gräler. 2009. Accumulation of fingolimod (FTY720) in lymphoid tissues contributes to prolonged efficacy. J. Pharmacol. Exp. Ther. 328: 963-969.
26. Billich, A., F. Bornancin, P. Dévay, D. Mechtcheriakova, N. Urtz, and T. Baumruker. 2003. Phosphorylation of the immunomodulatory drug FTY720 by sphingosine kinases. J. Biol. Chem. 278: 47408-47415.
27. Gräler, M. H., M. C. Huang, S. Watson, and E. J. Goetzl. 2005. Immunological effects of transgenic constitutive expression of the type 1 sphingosine 1-phosphate receptor by mouse lymphocytes. J. Immunol. 174: 1997-2003.
28. Hänel, P., P. Andréani, and M. H. Gräler. 2007. Erythrocytes store and release sphingosine 1-phosphate in blood. FASEB J. 21: 1202-1209. (Pubitemid 46495709)
29. Zhao, Y., S. K. Kalari, P. V. Usatyuk, I. Gorshkova, D. He, T. Watkins, D. N. Brindley, C. Sun, R. Bittman, J. G. Garcia, et al. 2007. Intracellular generation of sphingosine 1-phosphate in human lung endothelial cells: role of lipid phosphate phosphatase-1 and sphingosine kinase 1. J. Biol. Chem. 282: 14165-14177.
30. Zhang, K., J. M. Pompey, F. F. Hsu, P. Key, P. Bandhuvula, J. D. Saba, J. Turk, and S. M. Beverley. 2007. Redirection of sphingolipid metabolism toward de novo synthesis of ethanolamine in Leishmania. EMBO J. 26: 1094-1104.
31. Waymire, K. G., J. D. Mahuren, J. M. Jaje, T. R. Guilarte, S. P. Coburn, and G. R. MacGregor. 1995. Mice lacking tissue non-specific alkaline phosphatase die from seizures due to defective metabolism of vitamin B-6. Nat. Genet. 11: 45-51.
32. Hagen, N., P. P. Van Veldhoven, R. L. Proia, H. Park, A. H. Merrill, Jr., and G. van Echten-Deckert. 2009. Subcellular origin of sphingosine 1-phosphate is essential for its toxic effect in lyase-deficient neurons. J. Biol. Chem. 284: 11346-11353.
33. Brinkmann, V., M. D. Davis, C. E. Heise, R. Albert, S. Cottens, R. Hof, C. Bruns, E. Prieschl, T. Baumruker, P. Hiestand, et al. 2002. The immune modulator FTY720 targets sphingosine 1-phosphate receptors. J. Biol. Chem. 277: 21453-21457.
34. O'Leary, J. G., M. Goodarzi, D. L. Drayton, and U. H. von Andrian. 2006. T cell- and B cell-independent adaptive immunity mediated by natural killer cells. Nat. Immunol. 7: 507-516.
35. Tedesco-Silva, H., G. Mourad, B. D. Kahan, J. G. Boira, W. Weimar, S. Mulgaonkar, B. Nashan, S. Madsen, B. Charpentier, P. Pellet, and Y. Vanrenterghem. 2005. FTY720, a novel immunomodulator: efficacy and safety results from the first phase 2A study in de novo renal transplantation. Transplantation 79: 1553-1560.